ReviewAmerican journal of respiratory cell and molecular biology2021

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges.

Hongpeng Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.